Crispr Therapeutics shares owned by Lenox Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Lenox Wealth Management
from 13F filings
Historical chart of Lenox Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Lenox Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Lenox Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2020-06-30 | $286k | 3.9k | 73.37 |
| 2020-03-31 | $93k | 2.2k | 42.31 |
| 2019-12-31 | $134k | 2.2k | 60.96 |
| 2019-09-30 | $90k | 2.2k | 40.95 |
| 2019-06-30 | $103k | 2.2k | 46.86 |
| 2019-03-31 | $79k | 2.2k | 35.94 |
| 2018-12-31 | $11k | 120 | 91.67 |
| 2018-09-30 | $23k | 336 | 68.45 |